Study: CRO turnover rate remains high; ScinoPharm readies $113M new plant;

> CROs could improve their employee turnover rates if they brought annual incentives up to par with other industries, according to a survey. More

> CMO ScinoPharm has wrapped up construction on a $113 million active pharmaceutical ingredient facility in China. Story

> Canadian CRO Algorithme Pharma has partnered with Qeubec's Hôpital Maisonneuve-Rosemont to collaborate on early-stage clinical trials. News

Suggested Articles

Major CRO player Pharmaceutical Product Development is set to go back on the public markets after announcing its IPO plans.

Dubbed “Project Nightingale,” the efforts were announced amid concerns and federal inquiries into the data’s safekeeping and patient consent for use.

Independent site management organization Panthera Biopartners has kick-started its first clinical trial in the U.K.